Sharon Worcester is an award-winning medical journalist for MDedge News. She has been with the company since 1996, first as the Southeast Bureau Chief (1996-2009) when the company was known as International Medical News Group, then as a freelance writer (2010-2015) before returning as a reporter in 2015. She previously worked as a daily newspaper reporter covering health and local government. Sharon currently reports primarily on oncology and hematology. She has a BA from Eckerd College and an MA in Mass Communication/Print Journalism from the University of Florida. Connect with her via LinkedIn and follow her on twitter @SW_MedReporter.
News
FDA expands pembrolizumab approval for advanced melanoma
Approval was based on first interim findings from the randomized, placebo-controlled KEYNOTE-716 trial, which evaluated patients with stage IIB...
News
CLL and COVID-19: Outcome trends and lessons learned
Data highlight opportunities for further investigation into optimal management of COVID-19, immune response after infection, and effective...
News
Differences in response to immunotherapy in men versus women
It remains unclear whether the increased risk for death in women is a result of treatment side effects or lack of efficacy.
News
Easing access to DLBCL treatments: Patient study reveals racial differences
Collaborative follow-up models could improve access to cellular therapies, but more customized strategies are also needed.
News
Most oncology trainees encounter discrimination, don’t report it, survey finds
“I thought at some point [the racism and discrimination] would stop, but after all that training. . .I still had to prove myself.”
News
Cancer drug revenue increased 70% over a decade
“Cancer drugs now account for approximately 27% of new drug approvals in the United States, compared to 4% in the 1980s.”
News
Should you tell your doctor that you’re a doctor?
“I wouldn’t have treated him differently, but I just could have discussed the procedure with him in more professional terms.”
News
Data from Spain yield new insights on a rare hemophilia
Findings show high rates of antithrombotic use before diagnosis and fatal infections after immunosuppressive therapy starts.
News
CAR T for ALL: Areas that need optimizing
CAR T-cell therapy optimization is needed in a range of key areas.
News
On improving DLBCL outcomes, single-agent regimens fall short
Single-agent regimens are most likely not efficient enough to substantially improve outcomes of DLBCL patients.
News
COVID boosters help protect blood cancer patients, but some still vulnerable
Some patients with hematologic malignancies who are seronegative after a full course of COVID-19 vaccination may benefit from a booster.
News
Response to preop immunotherapy predicts survival in early NSCLC
For each 10% increase of residual viable tumor, risk of death was increased 64% and risk of recurrence was increased 71%.
News
Studies confirm survival benefit with postchemoradiotherapy consolidation in NSCLC
The findings show a progression-free survival benefit in patients who underwent concurrent or sequential chemoradiotherapy giving insight to real-...